BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 2885753)

  • 1. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma.
    Zbar B; Brauch H; Talmadge C; Linehan M
    Nature; 1987 Jun 25-Jul 1; 327(6124):721-4. PubMed ID: 2885753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma.
    Anglard P; Tory K; Brauch H; Weiss GH; Latif F; Merino MJ; Lerman MI; Zbar B; Linehan WM
    Cancer Res; 1991 Feb; 51(4):1071-7. PubMed ID: 1671754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma.
    Yamakawa K; Morita R; Takahashi E; Hori T; Ishikawa J; Nakamura Y
    Cancer Res; 1991 Sep; 51(17):4707-11. PubMed ID: 1678685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferential loss of maternal alleles in sporadic Wilms' tumour.
    Pal N; Wadey RB; Buckle B; Yeomans E; Pritchard J; Cowell JK
    Oncogene; 1990 Nov; 5(11):1665-8. PubMed ID: 1980007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
    Hughson MD; Bigler S; Dickman K; Kovacs G
    Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of papillary renal cell tumours is associated with loss of Y-chromosome-specific DNA sequences.
    Kovacs G; Tory K; Kovacs A
    J Pathol; 1994 May; 173(1):39-44. PubMed ID: 7931836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
    el-Naggar AK; Batsakis JG; Wang G; Lee MS
    Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic loss at chromosome 3p characterizes clear cell phenotype of renal cell carcinoma.
    Ogawa O; Kakehi Y; Ogawa K; Koshiba M; Sugiyama T; Yoshida O
    Cancer Res; 1991 Feb; 51(3):949-53. PubMed ID: 1671000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas.
    Kovacs A; Storkel S; Thoenes W; Kovacs G
    J Pathol; 1992 Jul; 167(3):273-7. PubMed ID: 1381433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning of a new familial t(3;8) translocation associated with conventional renal cell carcinoma reveals a 5 kb microdeletion and no gene involved in the rearrangement.
    Rodríguez-Perales S; Meléndez B; Gribble SM; Valle L; Carter NP; Santamaría I; Conde L; Urioste M; Benítez J; Cigudosa JC
    Hum Mol Genet; 2004 May; 13(9):983-90. PubMed ID: 15016767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelotype of renal cell carcinoma.
    Morita R; Ishikawa J; Tsutsumi M; Hikiji K; Tsukada Y; Kamidono S; Maeda S; Nakamura Y
    Cancer Res; 1991 Feb; 51(3):820-3. PubMed ID: 1670999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal abnormalities in renal cell neoplasms associated with acquired renal cystic disease. A series studied by comparative genomic hybridization and fluorescence in situ hybridization.
    Gronwald J; Baur AS; Holtgreve-Grez H; Jauch A; Mosimann F; Jichlinski P; Wauters JP; Cremer T; Guillou L
    J Pathol; 1999 Feb; 187(3):308-12. PubMed ID: 10398084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosome 5 allele loss in human colorectal carcinomas.
    Solomon E; Voss R; Hall V; Bodmer WF; Jass JR; Jeffreys AJ; Lucibello FC; Patel I; Rider SH
    Nature; 1987 Aug 13-19; 328(6131):616-9. PubMed ID: 2886919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer.
    Naylor SL; Johnson BE; Minna JD; Sakaguchi AY
    Nature; 1987 Oct 1-7; 329(6138):451-4. PubMed ID: 2821400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization.
    Speicher MR; Schoell B; du Manoir S; Schröck E; Ried T; Cremer T; Störkel S; Kovacs A; Kovacs G
    Am J Pathol; 1994 Aug; 145(2):356-64. PubMed ID: 7519827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional loss of chromosome 6 in two urological malignancies.
    Rukstalis DB; Bubley GJ; Donahue JP; Richie JP; Seidman JG; DeWolf WC
    Cancer Res; 1989 Sep; 49(18):5087-90. PubMed ID: 2766279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. About the origin and development of hereditary conventional renal cell carcinoma in a four-generation t(3;8)(p14.1;q24.23) family.
    Valle L; Cascón A; Melchor L; Otero I; Rodríguez-Perales S; Sánchez L; Cruz Cigudosa J; Robledo M; Weber B; Urioste M; Benítez J
    Eur J Hum Genet; 2005 May; 13(5):570-8. PubMed ID: 15756303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.